TORONTO, Nov. 17, 2020 /CNW/ - Alcon, the global leader in eye care, is pleased to announce the Canadian launch of AcrySof ® IQ Vivity ®, a first-of-its-kind, surgical lens designed to help cataract ...

Vivity complements Alcon’s existing IOL portfolio by providing an additional option for cataract patients to treat presbyopia A first-of-its-kind, non-diffractive lens that offers a continuous ...

For almost 20 years now, we have been using presbyopia-correcting lens implants. But an important caveat that came with all of them is that they can only be used safely in eyes with near-perfect ...

Please provide your email address to receive an email when new articles are posted on . WAILEA, Hawaii — The AcrySof IQ Vivity IOL features less glare and fewer halos with “significantly fewer ...

Alcon Inc. ALC recently announced the availability of Clareon Vivity — the first and only non-diffractive extended depth of focus (EDOF) intraocular lens (IOL) on Alcon’s most advanced lens platform ...

FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity ...

Two specialists at Phoenix-based Valley Eye Specialists were among the first group of surgeons in the nation to implant the Alcon Acrysof IQ Vivity Lens after FDA approval, according to a Feb. 1 news ...

Multifocal lenses use multiple refractive zones built in rings to give patients distance and near vision. These lenses are designed to address the problem of presbyopia, in which people over the age ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE:ALC), the global leader in eye care announced AcrySof® IQ Vivity®, a first-of-its-kind intraocular lens (IOL) is now commercially available in select European ...